Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed +101.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
SBC / revenue changed -555 basis points from the comparable as-filed period.
Operating income changed +163.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Working capital / assets changed +719 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +3847 basis points from the comparable as-filed period.
Stock-based compensation changed +18.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed +20.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed +10.3% from the comparable as-filed period.
R&D / revenue changed -45 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.